Torrent Pharma promoter offloads 2.9 percent stake for Rs 3086 crore

Published On 2024-11-05 07:00 GMT   |   Update On 2024-11-05 07:00 GMT
Advertisement

New Delhi: Torrent Investments, a promoter entity of Torrent Pharmaceuticals, has offloaded a total of 99.44 lakh shares or 2.94 per cent stake in the company. This sale was conducted through open market transactions and generated proceeds of approximately Rs 3,086 crore.

The shares were sold in the price range of Rs 3,103.07-3,104.40 apiece, taking the combined transaction value to Rs 3,086.37 crore.

Advertisement
According to PTI, the combined holding of promoters of Torrent Pharmaceuticals has come down to 68.31 per cent from 71.25 per cent after the stake sale.
Details of the buyers of Torrent Pharmaceuticals' shares could not be ascertained on the BSE.
Last week, Torrent Pharmaceuticals reported its consolidated profit after tax rose 17 per cent to Rs 453 crore in the September quarter, led by robust sales in the domestic market.
The drug firm had reported a profit after tax (PAT) of Rs 386 crore in the July-September period of the last fiscal.
During the period under review, revenues rose to Rs 2,889 crore compared to Rs 2,660 crore in the year-ago period.
The company said its India revenues increased 13 per cent to Rs 1,632 crore, led by outperformance in focus therapies, it added.

Torrent Pharma is an Indian multinational pharmaceutical company headquartered in Ahmedabad, India. The company specializes in therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI) and women healthcare (WHC).

Read also: Torrent Pharma is said to seek raising USD 3 billion for KKR stake in JB Chemicals: Report

Tags:    
Article Source : with inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News